Association of Polypharmacy and Statin New-User Adherence in a Veterans Health Administration Population: A Retrospective Cohort Study

Annals of Pharmacotherapy

Volumn 47, Issue 10, 2013, Pages 1253-1259

  Watanabe, Jonathan H ^a   Bounthavong, Mark ^b   Chen, Timothy ^b   Ney, John P ^c  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

dyslipidemia; medication possession ratio; polypharmacy

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; COCHRAN ARMITAGE TREND TEST; COHORT ANALYSIS; COMORBIDITY; CORRELATION ANALYSIS; DRUG UTILIZATION; DYSLIPIDEMIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MEDICATION POSSESSION RATIO; MULTIPLE LINEAR REGRESSION ANALYSIS; POLYPHARMACY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL PARAMETERS; TREND STUDY; VETERAN;

DYSLIPIDEMIA; MEDICATION POSSESSION RATIO; POLYPHARMACY;

AGED; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; POLYPHARMACY; RETROSPECTIVE STUDIES; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VETERANS;

EID: 84888073559     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/1060028013502000     Document Type: Article

References (33)

1. Viktil KK,Blix HS,Moger TA,Reikvam A.Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems.Br J Clin Pharmacol. 2007;63:187-195.
2. Kroenke K.Polypharmacy: causes, consequences, and cure.Am J Med. 1985;79:149-152.
3. Steinman MA,Hanlon JT.Managing medications in clinically complex elders: "There's got to be a happy medium.".JAMA. 2010;304:1592-1601.
4. Steinman MA,Landefeld CS,Rosenthal GE,Berthenthal D,Sen S,Kaboli PJ.Polypharmacy and prescribing quality in older people.J Am Geriatr Soc. 2006;54:1516-1523.
5. Grant RW,Devita NG,Singer DE,Meigs JB.Polypharmacy and medication adherence in patients with type 2 diabetes.Diabetes Care. 2003;26:1408-1412.
6. Shalansky SJ,Levy AR.Effect of number of medications on cardiovascular therapy adherence.Ann Pharmacother. 2002;36:1532-1539.
7. George J,Shalansky SJ.Predictors of refill non-adherence in patients with heart failure.Br J Clin Pharmacol. 2007;63:488-493.
8. Coons SJ,Sheahan SL,Martin SS,Hendricks J,Robbins CA,Johnson JA.Predictors of medication noncompliance in a sample of older adults.Clin Ther. 1994;16:110-117.
9. Sharkness CM,Snow DA.The patient's view of hypertension and compliance.Am J Prev Med. 1992;8:141-146.
10. Billups SJ,Malone DC,Carter BL.The relationship between drug therapy noncompliance and patient characteristics, health-related quality of life, and health care costs.Pharmacotherapy. 2000;20:941-949.
11. Col N,Fanale JE,Kronholm P.The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly.Arch Intern Med. 1990;150:841-845.
12. Horne R,Weinman J.Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness.J Psychosom Res. 1999;47:555-567.
13. Osterberg L,Blaschke T.Adherence to medication.N Engl J Med. 2005;353:487-497.
14. Schmier JK,Halpern MT.Patient recall and recall bias of health state and health status.Expert Rev Pharmacoecon Outcomes Res. 2004;4:159-163.
15. Stull DE,Leidy NK,Parasuraman B,Chassany O.Optimal recall periods for patient-reported outcomes: challenges and potential solutions.Curr Med Res Opin. 2009;25:929-942.
16. Berk RA.An introduction to sample selection bias in sociological data.Am Sociol Rev. 1983;48:.
17. Golin CE,Liu H,Hays RDet al.A prospective study of predictors of adherence to combination antiretroviral medication.J Gen Intern Med. 2002;17:756-765.
18. Arnsten JH,Demas PA,Farzadegan Het al.Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring.Clin Infect Dis. 2001;33:1417-1423.
19. Halpern MT,Khan ZM,Schmier JKet al.Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data.Hypertension. 2006;47:1039-1048.
20. Cochran WG.Some methods for strengthening the common; 2 tests.Biometrics. 1954;10:.
21. Armitage P.Tests for linear trends in proportions and frequencies.Biometrics. 1955;11:.
22. Oleen-Burkey MA,Dor A,Castelli-Haley J,Lage MJ.The relationship between alternative medication possession ratio thresholds and outcomes: evidence from the use of glatiramer acetate.J Med Econ. 2011;14:739-747.
23. Rosenstock IM.Why people use health services.Milbank Mem Fund Q. 1966;44:.
24. Scheurer D,Choudhry N,Swanton KA,Matlin O,Shrank W.Association between different types of social support and medication adherence.Am J Manag Care. 2012;18:e461-e467.
25. Lehavot K,Huh D,Walters KL,King KM,Andrasik MP,Simoni JM.Buffering effects of general and medication-specific social support on the association between substance use and HIV medication adherence.AIDS Patient Care STDS. 2011;25:181-189.
26. George J,Phun Y-T,Bailey MJ,Kong DC,Stewart K.Development and validation of the Medication Regimen Complexity Index.Ann Pharmacother. 2004;38:1369-1376.
27. Ray WA.Evaluating medication effects outside of clinical trials: new-user designs.Am J Epidemiol. 2003;158:915-920.
28. Grabowski DC,Lakdawalla DN,Goldman DPet al.The large social value resulting from use of statins warrants steps to improve adherence and broaden treatment.Health Aff (Millwood). 2012;31:2276-2285.
29. Kastelein JJP,van der Steeg WA,Holme Iet al.Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment.Circulation. 2008;117:3002-3009.
30. Degli Esposti L,Saragoni S,Batacchi Pet al.Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis.Clin Ther. 2012;34:190-199.
31. Martinez ML,Vande Griend JP,Linnebur SA.Medication management: a case of brown bag-identified medication hoarding.Consult Pharm. 2012;27:729-736.
32. Nathan A,Goodyer L,Lovejoy A,Rashid A."Brown bag" medication reviews as a means of optimizing patients' use of medication and of identifying potential clinical problems.Fam Pract. 1999;16:278-282.
33. Howard AA,Arnsten JH,Lo Yet al.A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women.AIDS. 2002;16:2175-2182.